2024 - Equasens: growth of almost 3% in annual turnover

(CercleFinance.com) – Equasens posts 2023 turnover up 2.6% to 219.7 million euros (+3.3% on a comparable basis), despite an unfavorable base effect linked to Ségur and a difficult economic situation, particularly in the pharmacy market.

In the fourth quarter of the past year alone, the group of software solutions for the health sector saw its turnover fall to 57 million euros (-5.5% compared to the last quarter of 2022, but +0.4% on a comparable basis).

‘The macroeconomic environment looks set to be more favorable in 2024, with a decline in inflation, a drop in financing rates and an expected restart of pharmacy activity during the first half of the year,’ he nevertheless underlines. .

Did you like this article ? Share it with your friends using the buttons below.